The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-PD-1 antibody SHR-1210 combined with apatinib as adjuvant treatment in patients with hepatocellular carcinoma at high risk of recurrence after radical resection: Preliminary results from a multicenter, randomized, controlled phase II trial.
 
Hong Zhao
No Relationships to Disclose
 
Jianjun Zhao
No Relationships to Disclose
 
Li Jiang
No Relationships to Disclose
 
Xinyu Bi
No Relationships to Disclose
 
Honggang Qian
No Relationships to Disclose
 
Shunda Du
No Relationships to Disclose
 
Jianqiang Cai
No Relationships to Disclose
 
Jianguo Zhou
No Relationships to Disclose
 
Zhiyu Li
No Relationships to Disclose
 
Dongbin Liu
No Relationships to Disclose
 
Yubao Zhang
No Relationships to Disclose
 
Ping Zhang
No Relationships to Disclose